BENGALURU: Union Minister of State for Science and Technology and Earth Sciences Jitendra Singh on Thursday emphasised the ...

"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

HONG KONG: If investors in China's biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd struck last month with Seattle-based Seagen ...

Biotechnology remains a priority sector in India, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh on Monday. He noted that the sector holds ...

New Delhi: Biotechnology remains a priority sector in India, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh Monday. He noted that the sector holds ...

He stressed the need for increased cooperation to bring cutting-edge innovations to the state. “Biotechnology remains a priority sector under the present government,” said Singh, while assuring “full ...

Investing in biotech can be a tricky business, but the rewards on offer - more than almost any other sector of the stock market, I'd speculate, stock prices surge by triple-digit percentages ...

In trading on Monday, biotechnology shares were relative laggards, down on the day by about 4.9%. Helping drag down the group were shares of Vaxcyte, down about 50.5% and shares of Taysha Gene ...